Collaborative Activities to Promote Metabolomics Research (Admin Supp)

Funding Agency:
National Institutes of Health

This Administrative Supplement funding opportunity is part of the Common Fund Metabolomics Program created to increase and improve the nation’s ability to undertake metabolomics analyses in translational and clinical research. Metabolomics has great potential to advance our understanding of human diseases, but requires specialized expertise in metabolomics study design, technology, and data analysis and interpretation. This FOA supports supplemental funds to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to add a metabolomics approach to the existing Research Strategy for the project. In addition to enhancing the parent grant by adding metabolomics analyses, collaborative projects must include activities to increase the expertise of the biomedical research group in key aspects of metabolomics study design, analysis, and data interpretation.

All applicants are strongly encouraged to discuss potential requests with the awarding IC and with the Common Fund Metabolomics Scientific/Research contact.

Only one application per parent award is allowed.

Application Due Date(s): February 15, 2016, by 5:00 PM local time of applicant organization.

PA-16-005 Expiration Date February 16, 2016

Agency Website

Eligibility Requirements

All organizations administering an eligible parent award may apply for a supplement under this announcement.



Amount Description

Application budgets are limited to no more than $100,000 direct costs, exclusive of consortium/contractual Facilities and Administrative (F&A) costs, and must reflect the actual needs of the proposed project.

The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the peer reviewed and approved project. Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 15, 2016